Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonoporation with Chemotherapy for Pancreatic Cancer
NCT04821284Phase 2Active, not recruiting
- Start
- Dec 2021
- Primary completion
- Oct 2025
- Modality
- Nanoparticles
- Countries
- 2
01
Overview
A Phase 2 trial of sonazoid in pancreatic ductal adenocarcinoma (PDAC). Started Dec 2021; status: active, not recruiting.
02
Drugs
sonazoid
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04821284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821284.